High-Throughput Quantitative Screening of Glucose-Stimulated Insulin Secretion and Insulin Content Using Automated MALDI-TOF Mass Spectrometry
Cells · 2023
DOI: 10.3390/cells12060849 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Clément Philippe Delannoy und 11 weiteren Autor:innen. Beteiligte Einrichtung: Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, CNRS, U1283-UMR 8199-EGID, F-59000 Lille, France. Hauptthemen laut MEDLINE: Insulin, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conseil Régional Hauts de France and I-SITE ULNE, National Research Agency, Fondation pour la Recherche Médicale.
Abstract (Originalsprache)
Type 2 diabetes (T2D) is a metabolic disorder characterized by loss of pancreatic β-cell function, decreased insulin secretion and increased insulin resistance, that affects more than 537 million people worldwide. Although several treatments are proposed to patients suffering from T2D, long-term control of glycemia remains a challenge. Therefore, identifying new potential drugs and targets that positively affect β-cell function and insulin secretion remains crucial. Here, we developed an automated approach to allow the identification of new compounds or genes potentially involved in β-cell function in a 384-well plate format, using the murine β-cell model Min6. By using MALDI-TOF mass spectrometry, we implemented a high-throughput screening (HTS) strategy based on the automation of a cellular assay allowing the detection of insulin secretion in response to glucose, i.e., the quantitative detection of insulin, in a miniaturized system. As a proof of concept, we screened siRNA targeting well-know β-cell genes and 1600 chemical compounds and identified several molecules as potential regulators of insulin secretion and/or synthesis, demonstrating that our approach allows HTS of insulin secretion in vitro.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, CNRS, U1283-UMR 8199-EGID, F-59000 Lille, France.
- Univ. Lille, CNRS, Centrale Lille, Univ. Artois, UMR 8181-UCCS-Unité de Catalyse et de Chimie du Solide, F-59000 Lille, France.
- Univ. Lille, Inserm, Institut Pasteur de Lille, U1177-Drugs and Molecule for Living Systems, F-59000 Lille, France.
- Univ. Lille, UMRt BioEcoAgro 1158-INRAE, Équipe Métabolites Secondaires D'origine Microbienne, Institut Charles Viollette, F-59000 Lille, France.
- Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1167-RID-AGE-Facteurs de Risque et Determinants Moléculaires des Maladies liées au Vieillissement, F-59000 Lille, France.
ORCID-Profile: Clément Philippe Delannoy, Egon Heuson, Frederik Oger, Benoit Deprez, Sébastien Paul, Jean-Sébastien Annicotte
Förderung
- Conseil Régional Hauts de France and I-SITE ULNE
- National Research Agency
- Fondation pour la Recherche Médicale
Zitieren
APA
Delannoy, C. P., Heuson, E., Herledan, A., Oger, F., Thiroux, B., Chevalier, M., Gromada, X., Rolland, L., Froguel, P., Deprez, B., Paul, S., & Annicotte, J. S. (2023). High-Throughput Quantitative Screening of Glucose-Stimulated Insulin Secretion and Insulin Content Using Automated MALDI-TOF Mass Spectrometry. Cells. https://doi.org/10.3390/cells12060849
Vancouver
Delannoy CP, Heuson E, Herledan A, Oger F, Thiroux B, Chevalier M, et al. High-Throughput Quantitative Screening of Glucose-Stimulated Insulin Secretion and Insulin Content Using Automated MALDI-TOF Mass Spectrometry. Cells. 2023. doi:10.3390/cells12060849
BibTeX
@article{Delannoy2023,
author = {Delannoy, Clément Philippe and Heuson, Egon and Herledan, Adrien and Oger, Frederik and Thiroux, Bryan and Chevalier, Mickaël and Gromada, Xavier and Rolland, Laure and Froguel, Philippe and Deprez, Benoit and Paul, Sébastien and Annicotte, Jean-Sébastien},
title = {High-Throughput Quantitative Screening of Glucose-Stimulated Insulin Secretion and Insulin Content Using Automated MALDI-TOF Mass Spectrometry},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12060849}
}
EUVIMED